Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 113 of 113 entries
Sorted by: Best Match Show Resources per page
Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Papke DJ, Dong F, Zhang X, Kozielski R, Basturk O, Fletcher CDM, Zhao L.
PMID: 33994539
Mod Pathol. 2021 Sep;34(9):1696-1703. doi: 10.1038/s41379-021-00822-w. Epub 2021 May 16.

Calcifying nested stromal-epithelial tumor (CNSET) is a rare hepatic tumor that occurs in children and young adults. With

Cite
Papke DJ, Dong F, Zhang X, et al. Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations. Mod Pathol. 2021;34(9):1696-1703doi: 10.1038/s41379-021-00822-w.
Papke, D. J., Dong, F., Zhang, X., Kozielski, R., Basturk, O., Fletcher, C. D. M., & Zhao, L. (2021). Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 34(9), 1696-1703. https://doi.org/10.1038/s41379-021-00822-w
Papke, David J, et al. "Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 34,9 (2021): 1696-1703. doi: https://doi.org/10.1038/s41379-021-00822-w
Papke DJ, Dong F, Zhang X, Kozielski R, Basturk O, Fletcher CDM, Zhao L. Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations. Mod Pathol. 2021 Sep;34(9):1696-1703. doi: 10.1038/s41379-021-00822-w. Epub 2021 May 16. PMID: 33994539.
Copy Download .nbib Format: NLM
Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study.

Ophthalmology

Leng T, Gallivan MD, Kras A, Lum F, Roe MT, Li C, Parke DW, Schwartz SD.
PMID: 34144077
Ophthalmology. 2021 Dec;128(12):1782-1784. doi: 10.1016/j.ophtha.2021.06.011. Epub 2021 Jun 16.

No abstract available.

Cite
Leng T, Gallivan MD, Kras A, et al. Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study. Ophthalmology. 2021;128(12):1782-1784doi: 10.1016/j.ophtha.2021.06.011.
Leng, T., Gallivan, M. D., Kras, A., Lum, F., Roe, M. T., Li, C., Parke, D. W., & Schwartz, S. D. (2021). Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study. Ophthalmology, 128(12), 1782-1784. https://doi.org/10.1016/j.ophtha.2021.06.011
Leng, Theodore, et al. "Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study." Ophthalmology vol. 128,12 (2021): 1782-1784. doi: https://doi.org/10.1016/j.ophtha.2021.06.011
Leng T, Gallivan MD, Kras A, Lum F, Roe MT, Li C, Parke DW, Schwartz SD. Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study. Ophthalmology. 2021 Dec;128(12):1782-1784. doi: 10.1016/j.ophtha.2021.06.011. Epub 2021 Jun 16. PMID: 34144077; PMCID: PMC8213986.
Copy Download .nbib Format: NLM
Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors.

Bioorganic & medicinal chemistry letters

Morriello GJ, Dwyer MP, Chen Y, Ginetti AT, Xu S, Lu J, Abeywickrema P, Wang D, Crespo A, Cabalu TD, Wilson JE, Stachel SJ, Paone DV, Sinz C.
PMID: 33991626
Bioorg Med Chem Lett. 2021 Jul 15;44:128082. doi: 10.1016/j.bmcl.2021.128082. Epub 2021 May 13.

A focused SAR study was conducted on a series of N1-substituted pyrazolopyrimidinone PDE2 inhibitors to reveal compounds with excellent potency and selectivity. The series was derived from previously identified internal leads and designed to enhance steric interactions with key...

Cite
Morriello GJ, Dwyer MP, Chen Y, et al. Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors. Bioorg Med Chem Lett. 2021;44:128082doi: 10.1016/j.bmcl.2021.128082.
Morriello, G. J., Dwyer, M. P., Chen, Y., Ginetti, A. T., Xu, S., Lu, J., Abeywickrema, P., Wang, D., Crespo, A., Cabalu, T. D., Wilson, J. E., Stachel, S. J., Paone, D. V., & Sinz, C. (2021). Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors. Bioorganic & medicinal chemistry letters, 44128082. https://doi.org/10.1016/j.bmcl.2021.128082
Morriello, Gregori J, et al. "Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors." Bioorganic & medicinal chemistry letters vol. 44 (2021): 128082. doi: https://doi.org/10.1016/j.bmcl.2021.128082
Morriello GJ, Dwyer MP, Chen Y, Ginetti AT, Xu S, Lu J, Abeywickrema P, Wang D, Crespo A, Cabalu TD, Wilson JE, Stachel SJ, Paone DV, Sinz C. Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors. Bioorg Med Chem Lett. 2021 Jul 15;44:128082. doi: 10.1016/j.bmcl.2021.128082. Epub 2021 May 13. PMID: 33991626.
Copy Download .nbib Format: NLM
Translating 2019 ACSM Cancer Exercise Recommendations for a Physiatric Practice: Derived Recommendations from an International Expert Panel.

PM & R : the journal of injury, function, and rehabilitation

Parke SC, Ng A, Martone P, Gerber LH, Zucker DS, Engle J, Gupta E, Power K, Sokolof J, Shapar S, Bagay L, Becker BE, Langelier DM.
PMID: 34213826
PM R. 2021 Jul 02; doi: 10.1002/pmrj.12664. Epub 2021 Jul 02.

In 2018, the American College of Sports Medicine (ACSM) reconvened an international, multi-disciplinary group of professionals to review pertinent published literature on exercise for people with cancer. The 2018 roundtable resulted in the publication of three articles in 2019....

Cite
Parke SC, Ng A, Martone P, et al. Translating 2019 ACSM Cancer Exercise Recommendations for a Physiatric Practice: Derived Recommendations from an International Expert Panel. PM R. 2021;doi: 10.1002/pmrj.12664.
Parke, S. C., Ng, A., Martone, P., Gerber, L. H., Zucker, D. S., Engle, J., Gupta, E., Power, K., Sokolof, J., Shapar, S., Bagay, L., Becker, B. E., & Langelier, D. M. (2021). Translating 2019 ACSM Cancer Exercise Recommendations for a Physiatric Practice: Derived Recommendations from an International Expert Panel. PM & R : the journal of injury, function, and rehabilitation, . https://doi.org/10.1002/pmrj.12664
Parke, Sara C, et al. "Translating 2019 ACSM Cancer Exercise Recommendations for a Physiatric Practice: Derived Recommendations from an International Expert Panel." PM & R : the journal of injury, function, and rehabilitation vol. (2021). doi: https://doi.org/10.1002/pmrj.12664
Parke SC, Ng A, Martone P, Gerber LH, Zucker DS, Engle J, Gupta E, Power K, Sokolof J, Shapar S, Bagay L, Becker BE, Langelier DM. Translating 2019 ACSM Cancer Exercise Recommendations for a Physiatric Practice: Derived Recommendations from an International Expert Panel. PM R. 2021 Jul 02; doi: 10.1002/pmrj.12664. Epub 2021 Jul 02. PMID: 34213826.
Copy Download .nbib Format: NLM
PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.

The American journal of surgical pathology

Papke DJ, Forgó E, Charville GW, Hornick JL.
PMID: 33859072
Am J Surg Pathol. 2022 Jan 01;46(1):3-10. doi: 10.1097/PAS.0000000000001720.

Platelet-derived growth factor receptor A (PDGFRA) is a receptor tyrosine kinase that is activated by mutations in 10% of gastrointestinal stromal tumors (GISTs) and 55% to 70% of inflammatory fibroid polyps. PDGFRA-mutant GISTs are usually epithelioid and occur predominantly...

Cite
Papke DJ, Forgó E, Charville GW, et al. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors. Am J Surg Pathol. 2022;46(1):3-10doi: 10.1097/PAS.0000000000001720.
Papke, D. J., Forgó, E., Charville, G. W., & Hornick, J. L. (2022). PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors. The American journal of surgical pathology, 46(1), 3-10. https://doi.org/10.1097/PAS.0000000000001720
Papke, David J, et al. "PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors." The American journal of surgical pathology vol. 46,1 (2022): 3-10. doi: https://doi.org/10.1097/PAS.0000000000001720
Papke DJ, Forgó E, Charville GW, Hornick JL. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors. Am J Surg Pathol. 2022 Jan 01;46(1):3-10. doi: 10.1097/PAS.0000000000001720. PMID: 33859072.
Copy Download .nbib Format: NLM
Showing 109 to 113 of 113 entries